Form 4: Humana Director Gordon Smith Reports Acquisition of Restricted Stock Units

Director Gordon Smith reports acquisition of Humana restricted stock units through director's fees and stock incentive plan.

Summary

• Gordon Smith, a director at Humana Inc., filed a Form 4 detailing changes in beneficial ownership.
• The report indicates the acquisition of restricted stock units (RSUs) related to director's fees and the company's stock incentive plan.
• On March 31, 2025, Smith acquired 118 restricted stock units at a price of $263.875 per unit.
• These RSUs are payable in Humana Inc. common stock on a 1-for-1 basis.
• Smith also holds 765 restricted stock units under the company's 2019 Amended & Restated Stock Incentive Plan and 783 restricted stock units from deferred annual director's fees.
• These holdings represent a contingent right to receive one share of Humana Inc. common stock per unit.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing. The acquisition of shares by a director is generally viewed as a neutral to slightly positive signal.

Positives

• The acquisition of restricted stock units by a director can be seen as a positive sign, indicating confidence in the company's future performance.
• The director's decision to convert cash fees into stock units aligns their interests with those of shareholders.

Future Outlook

The document does not contain specific forward-looking statements regarding Humana's future performance.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency regarding the transactions of company insiders. This filing indicates a director's ongoing investment in the company.

Comparison to Industry Standards

• Director compensation in the form of stock and restricted stock units is a common practice among publicly traded companies, including Humana's competitors like UnitedHealth Group and CVS Health.
• The specific amounts and terms of these grants vary based on company size, performance, and individual director roles.
• Humana's 2019 Amended & Restated Stock Incentive Plan is similar to those offered by other large healthcare companies to align executive and director interests with shareholder value.

Stakeholder Impact

• The acquisition of restricted stock units by a director can have a minor positive impact on shareholder sentiment.
• It demonstrates the director's commitment to the company's long-term success.

Key Dates

Keywords

Form 4, Humana, Restricted Stock Units, Director, Beneficial Ownership, Gordon Smith, Stock Incentive Plan, Director's Fees